TELA Bio, Inc.
TELA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $69 | $58 | $41 | $29 |
| % Growth | 18.6% | 41.1% | 40.6% | – |
| Cost of Goods Sold | $23 | $18 | $14 | $11 |
| Gross Profit | $46 | $40 | $27 | $19 |
| % Margin | 67.1% | 68.6% | 65.3% | 63.9% |
| R&D Expenses | $9 | $10 | $9 | $7 |
| G&A Expenses | $15 | $15 | $14 | $12 |
| SG&A Expenses | $79 | $75 | $57 | $42 |
| Sales & Mktg Exp. | $65 | $60 | $43 | $29 |
| Other Operating Expenses | -$8 | $0 | $0 | $0 |
| Operating Expenses | $81 | $84 | $66 | $48 |
| Operating Income | -$34 | -$44 | -$39 | -$29 |
| % Margin | -49.2% | -75.4% | -94.2% | -100% |
| Other Income/Exp. Net | -$4 | -$3 | -$5 | -$4 |
| Pre-Tax Income | -$38 | -$47 | -$44 | -$33 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$38 | -$47 | -$44 | -$33 |
| % Margin | -54.6% | -79.8% | -106.9% | -112.9% |
| EPS | -1.33 | -2.04 | -2.73 | -2.3 |
| % Growth | 34.8% | 25.3% | -18.7% | – |
| EPS Diluted | -1.33 | -2.04 | -2.73 | -2.3 |
| Weighted Avg Shares Out | 29 | 23 | 16 | 14 |
| Weighted Avg Shares Out Dil | 29 | 23 | 16 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $5 | $4 | $4 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$32 | -$41 | -$39 | -$29 |
| % Margin | -45.7% | -69.5% | -94.3% | -98.9% |